LEADER 04096nam  2200889z- 450 
001 9910346691103321
005 20231214132819.0
010   $a3-03897-913-9
035   $a(CKB)4920000000094758
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/46161
035   $a(EXLCZ)994920000000094758
100   $a20202102d2019      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aElectrospun and electrosprayed formulations for drug delivery /$fspecial issue editors, Ian S. Blagbrough, Gareth R. Williams
210   $cMDPI - Multidisciplinary Digital Publishing Institute$d2019
215   $a1 electronic resource (190 p.)
311   $a3-03897-912-0 
330   $aThis book is comprised of important reviews and cutting-edge original research papers concerning electrospun and electrosprayed formulations in drug delivery. Electrospinning and electrospraying have, in recent years, attracted increasing attention in the pharmaceutical sector, with research in the area advancing rapidly. It is now possible to prepare extremely complex systems using multi-fluid processes, and to increase production rates to an industrial scale. Electrospun formulations can be produced under GMP conditions and are in clinical trials. In this volume, we explore a range of topics around electrospinning and electrospraying in controlled drug delivery. Four reviews cover the exciting potential of cyclodextrin-containing fibers and the many potential biomedical applications of electrospun fibers. The use of electrospinning to prepare amorphous systems and improve the dissolution rate and solubility of poorly soluble active ingredients is addressed, and the possibilities of such materials in tissue engineering are comprehensively covered. The six original research papers cover the effect of molecular properties on API release from Eudragit-based electrospun fibers; ferulic acid solid dispersions; electrospun medicines to treat psoriasis; scale up of electrospinning and its use to produce low-dose tablets; transepithelial permeation of drugs released from electrospun fibers, and the possibilities for the synergistic chemophotothermal treatment of cancer.
606   $aDrug delivery systems
606   $aElectrospinning
606   $aNanoparticles
610   $atissue engineering
610   $acyclodextrin
610   $apermeability
610   $apoly (vinylpyrrolidone-co-vinyl acetate)
610   $acrystalline
610   $aantibacterial
610   $adrug delivery
610   $ahomogenization
610   $acapsaicin
610   $acombination therapy
610   $ahigh-shear mixing
610   $acyclodextrin-inclusion complexes
610   $aamorphous
610   $ahigh-speed electrospinning
610   $aPMVE/MA
610   $aaqueous solubility enhancement
610   $asieve analysis
610   $aRaman mapping
610   $aEudragit
610   $ananofibers
610   $apsoriasis
610   $aPCL
610   $aessential oils
610   $aparameters
610   $aantibiotics
610   $axanthan gum
610   $acarvedilol
610   $aamorphous composite
610   $acoaxial electrospinning
610   $ainsoluble drug
610   $aNIR-triggered drug release
610   $afast dissolution
610   $aelectrospinning
610   $aoral drug delivery
610   $aelectrospun nanofibers
610   $apoly-cyclodextrin
610   $aTRPV1
610   $agallic acid
610   $asolid dispersion
610   $aphotothermal therapy
610   $adrug release
610   $aapplications
615  0$aDrug delivery systems.
615  0$aElectrospinning.
615  0$aNanoparticles.
676   $a615.1/9
702   $aBlagbrough$b I. S$g(Ian S.),
702   $aWilliams$b J. R. G.$f1978-
906   $aBOOK
912   $a9910346691103321
996   $aElectrospun and electrosprayed formulations for drug delivery$93401401
997   $aUNINA